Filing Flows › Endovia Health Sciences (EDVA) › Q1 2025 › vs Q4 2024
Endovia Health Sciences (EDVA) Q1 2025 vs Q4 2024 (quarter over quarter)
Endovia Health Sciences's revenue fell $148K (-25%) from $586K in Q4 2024 to $438K in Q1 2025.
Endovia Health Sciences, Q1 2025: revenue $438K (-72% year over year), operating margin -463.8%, net loss $3.7M, operating cash flow −$724K. The chart draws each line against Q4 2024, the increases inside each band.
Every line
| Line | Q1 2025 | Q4 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $438K | $586K | −$148K | -25% |
| Net loss | $3.7M | $9.0M | −$5.4M | -60% |
| Costs & expenses | $4.1M | $9.6M | −$5.5M | -58% |
| Operating costs | $2.5M | $7.0M | −$4.6M | -65% |
| Interest & other, net | $1.6M | $2.6M | −$986K | -38% |
| Cost of revenue | $469K | $930K | −$461K | -50% |
| Sales & marketing | $43K | $105K | −$62K | -59% |
| Other operating costs | $2.0M | $6.0M | −$4.0M | -67% |
| Operating cash sources | $3.7M | $9.0M | −$5.4M | -60% |
| Depreciation | $37K | $135K | −$98K | -73% |
| Share-based compensation | $141K | $265K | −$124K | -47% |
| Working capital & other | $2.7M | $7.0M | −$4.3M | -61% |
| Cash used in operations | $724K | $1.6M | −$896K | -55% |
| Net loss absorbed | $3.7M | $9.0M | −$5.4M | -60% |
Questions
How much did Endovia Health Sciences's revenue grow quarter over quarter in Q1 2025?
Endovia Health Sciences's revenue fell $148K (-25%) from $586K in Q4 2024 to $438K in Q1 2025.